StemCells (STEM) Reports In-Line Q4 EPS

March 23, 2016 4:07 PM EDT

StemCells (NASDAQ: STEM) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $28 thousand versus the consensus estimate of $30 thousand.

For earnings history and earnings-related data on StemCells (STEM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings